Nebius Stock Jumps 19% Ahead of Q3 as CoreWeave Backlog Hits $132.5 Billion

Nebius shares surged to $159.39 before third-quarter results, as CoreWeave’s booming backlog reignited confidence in AI cloud demand. Investors now face a critical earnings test for Nebius’s revenue, ARR and capital spending outlook.

Nebius stock surged 18.95% to $159.39 in Nasdaq trading on November 11, adding urgency to an already high-stakes earnings setup. The move came just one day before the company’s third-quarter report, which is due before the U.S. market opens on November 12.

The rally was driven less by Nebius-specific news than by a powerful read-through from CoreWeave, whose third-quarter results showed revenue up 168% to $3.66 billion and contracted backlog expanding to $132.5 billion. That combination pushed investors to reprice the broader AI infrastructure and neocloud sector.

For Nebius, the timing matters. The stock had already fallen sharply from its June peak, and the earnings report now stands as a near-term verdict on whether its premium valuation, aggressive buildout and year-end run-rate targets remain intact.

Key Facts

  • Nebius shares rose $25.39, or 18.95%, to $159.39 on November 11 after closing at $134.00 on November 10.
  • CoreWeave reported third-quarter revenue of $3.66 billion, up 168% year over year, with backlog growing to $132.5 billion from $104.2 billion at the end of June.
  • Nebius is scheduled to report third-quarter results before the market opens on November 12, with a conference call at 8:00 a.m. Eastern.
  • Consensus third-quarter revenue for Nebius is about $907 million, with analyst estimates ranging from $901 million to $917 million.
  • Even after the rally, Nebius remained 44.4% below its record closing high of $286.69 reached on June 18.

Nebius stock

The immediate catalyst for the rally was a broader reassessment of AI cloud demand. CoreWeave’s results suggested that end-market appetite for GPU capacity remains strong despite concerns over leverage, financing costs and slowing sentiment across high-growth infrastructure names. Investors interpreted the backlog increase and higher revenue outlook as evidence that demand is still outpacing available supply.

That matters directly to Nebius because the company operates in the same broad market: renting high-performance AI compute capacity, largely tied to Nvidia-powered infrastructure, to large enterprise and model-development customers. When a close peer shows accelerating backlog and improved confidence in forward revenue, it can reshape expectations across the sector, especially for companies about to report.

Still, Nebius faces a more difficult burden than simple sympathy gains suggest. At $159.39, the company carried an estimated market value near $43.3 billion, far above the multiple implied by some peers when measured against current revenue guidance. Investors are effectively paying in advance for rapid scaling, improving margins and successful execution on a massive capacity buildout. That leaves little room for a weak quarter, any softening in annualized run-rate revenue, or fresh signs that financing needs could dilute shareholders.

Strong sector demand may have lifted Nebius shares, but only Nebius can validate its valuation when it reports third-quarter results.

Why CoreWeave reset expectations

CoreWeave’s numbers addressed the market’s two biggest questions at once: whether AI infrastructure demand is still robust, and whether the economics of scaling can remain credible under higher interest rates. Revenue rose sharply, the backlog expanded by $28.3 billion in one quarter, and full-year revenue guidance increased to $13.0 billion to $13.3 billion.

That did not eliminate concern around losses or capital intensity, but it reduced fears of a worst-case scenario in which neocloud providers would overbuild just as customer demand cooled. For Nebius, the implication is clear: if the company can show comparable demand strength and reaffirm its own targets, investors may be willing to support a higher share price despite the sector’s elevated risk profile.

Implications for Investors

The next major test is whether Nebius can match market expectations on revenue while preserving confidence in its year-end trajectory. The consensus estimate of roughly $907 million would imply sequential growth of about 55.8% from second-quarter revenue of $582.3 million. That is an aggressive target, but one the market appears willing to believe if newly deployed capacity began billing on schedule through the quarter.

Beyond headline revenue, investors should focus on annualized run-rate revenue, adjusted EBITDA margin and capital expenditure guidance. Nebius has framed year-end ARR as the defining metric for its growth story, with a target range of $7 billion to $9 billion by December. A third-quarter ARR print above roughly $4.5 billion, combined with reaffirmed guidance, would likely support the argument that fourth-quarter acceleration is achievable. A meaningfully weaker figure could quickly revive fears that the stock’s premium multiple is vulnerable to compression.

Capital spending remains the central risk. Nebius has guided for 2026 capex of $20 billion to $25 billion and already spent $8.1 billion in the first half, including $5.7 billion in the second quarter. Investors will be looking for evidence that future expansion can be funded through a manageable mix of customer prepayments, asset-backed debt and existing liquidity rather than heavy new equity issuance. Any sign of additional dilution would likely overshadow otherwise solid operating results.

There is also concentration risk to monitor. Large contracts, including agreements tied to major hyperscale and platform customers, are a key part of the company’s growth assumptions. If management confirms that major tranches are billing on schedule and that customer diversification is improving, that would ease one of the market’s most persistent concerns. If not, the stock could remain highly sensitive to contract timing and counterparty dependence.

For portfolios, Nebius sits at the intersection of strong secular AI demand and unusually high execution risk. The upside case rests on demand remaining constrained by supply, not the other way around. The downside case is that revenue timing, capex intensity and funding costs prove less forgiving than the current valuation assumes. With options implying a move of about 20%, volatility around the earnings release appears fully expected.

Nebius now has a narrow window to convert sector enthusiasm into company-specific proof points. If the November 12 report confirms strong growth and stable guidance, the recent rebound could extend; if execution slips, investors may quickly refocus on valuation and financing risk.

Ultima Markets